Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Level 2 quotes

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon May 31, 2023 9:19am

339 Views

Post# 35472058

Level 2 quotes

The level 2 quotes look pretty much the same as yesterday. The large ask of 100,000 shares sits at 0.265. Otherwise no big new bids.

This tells us that the thing that is determining price action right now is NOT clinical data. The clinical data was very good. In any other biotech company the clinical data would cause a price spike.

It's all about the uncertainty of where the next installment of money may come from.

And the fact that the same pool of people cotinue to be the only ones who know anything about this company. No new buyers showing up yet.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale